PA
RDUS

Parallel Advisors’s Radius Health, Inc. RDUS Stock Holding History

Parallel Advisors’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-43
Closed -$1K – 2352
2018
Q3 		$1K Buy
+43
New +$973 ﹤0.01% 2184

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parallel Advisors's RDUS Position: Q4 2018 in Review

Parallel Advisors sold out of Radius Health, Inc. (RDUS) in Q4 2018, closing a stake of 43 shares — an estimated $1K sold.

Parallel Advisors first reported a position in RDUS in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 123 funds tracked by Wall St. Rank hold RDUS as of Q4 2018.

  • Parallel Advisors reported no remaining Radius Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Parallel Advisors sold 43 Radius Health, Inc. shares in Q4 2018, an estimated $1K.
  • Parallel Advisors first reported a position in Radius Health, Inc. in Q3 2018 and held it in 1 quarter.
  • Parallel Advisors's Radius Health, Inc. position peaked at $1K in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2018.

Based on Parallel Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.